ACP Rheumatology Pearls. Adam Q Carlson MD Assistant Professor UVA Rheumatology

Similar documents
Rheumatology Review Update in Internal Medicine COPYRIGHT. Robert H. Shmerling, M.D. Beth Israel Deaconess Medical Center.

Preventing blindness: Ultrasound in Giant cell arteritis

RHEUMATOLOGY OVERVIEW. Carmelita J. Colbert, MD Assistant Professor of Medicine Division of Rheumatology Loyola University Medical Center

THE KIDNEY AND SLE LUPUS NEPHRITIS

Gout 2.0. Scott Vogelgesang, M.D. Division of Immunology: Rheumatology & Allergy

CAN WE REPLACE TEMPORAL ARTERY BIOPSY WITH CRANIAL ULTRASOUND FOR THE DIAGNOSIS OF GIANT CELL ARTERITIS?

High Impact Rheumatology

HARVARD PILGRIM HEALTH CARE RECOMMENDED MEDICATION REQUEST GUIDELINES

Overview INTRODUCTION 3/15/2018. Headache Emergencies. Other way to differentiate between them? Is there an easy way to differentiate between them?

Patient with Daily Headache NTERNATIONAL CLASSIFICATION HEADACHE DISORDERS. R. Allan Purdy, MD, FRCPC,FACP. Professor of Medicine (Neurology)

VI.2 Elements for a Public Summary. VI.2.1 Overview of disease epidemiology

Limitations of Use: (1) Duzallo is not recommended for the treatment of asymptomatic hyperuricemia.

CME for Family Medicine Specialists. Evelyn Sutton, MD, FRCPC, FACP November 17, 2018

Additional file 2: Details of cohort studies and randomised trials

Case presentation. serum uric acid = 11.5 mg/dl 24-hour uric acid excretion = 300 mg

Drugs Used to Treat Gout. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia

Lupus Related Kidney Diseases. Jason Cobb MD Assistant Professor Renal Division Emory University School of Medicine October 14, 2017

Case # 2 3/27/2017. Disclosure of Relevant Financial Relationships. Clinical history. Clinical history. Laboratory findings

Year In Review: VasculitisPers. Disclosures. Learning Objectives. none 4/16/2018. Describe new medications for the treatment of vasculitis

UNFOLDING NATURE S ORIGAMI: MEDICAL TREATMENT OF TAKAYASU ARTERITIS AND GIANT CELL ARTERITIS

Lupus. Fast facts. What is lupus? What causes lupus? Who gets lupus?

Rheumatology Cases for the Internist

Index. Note: Page numbers of article titles are in boldface type.

Rheumatology Updates for the Primary Care Provider

Undifferentiated Connective Tissue Disease and Overlap Syndromes. Mark S. Box, MD

Rheumatologic Emergencies It s not just swollen joints. Joanne Homik Rheumatologist University of Alberta

Rheumatology Updates for Primary Care Olympic Peninsula Medical Conference. Erin M. Bauer MD Rheumatology

MEDICATIONS: THE GOOD, THE BAD, THE UGLY

To live with lupus, we need to know about lupus.

Gout: Update in therapeutics

Lupus. and the Kidneys

Sudden Vision Loss. Brendan Girschek, MD, FRCSC, FACS Vitreoretinal Surgery Cedar Valley Medical Specialists

Scott Vogelgesang, MD Division of Rheumatology/Immunology University of Iowa

Gout: Develop treatment plan in William Jones, MS, RPh

Lupus as a risk factor for cardiovascular disease

Professor Helen Danesh-Meyer. Eye Institute Auckland

Disclosures. Rheumatological Approaches to Differential Diagnosis, Physical Examination, and Interpretation of Studies. None

OBJECTIVES GOUT GOUTY INFLAMMATION 6/10/2016 GOUT INCIDENCE AND PREVALENCE MONOSODIUM URATE CRYSTAL DEPOSITION DISEASE

Managing Gout A Review of the Research for Adults

Enhanced Primary Care Pathway: Gout

Managing patients with bulky cancers

Osteoarthritis. Rheumatology Update. Gout 1/17/2013

Krystexxa. Krystexxa (pegloticase) Description

Dr. Venkateswari. R. Dr. Janani Sankar s unit Kanchi Kamakoti CHILDS Trust Hospital

Zurampic, Duzallo (lesinurad Products)

Uloric Step Therapy Program

Zurampic. (lesinurad) New Product Slideshow

Manifestations and Presentations of Collagen Vascular Diseases. Joseph LaConti, M.D., Ph.D. Center for Arthritis and Rheumatic Diseases Miami, FL

Gout- Treatment Updates. Harinder Singh, MD Rheumatology Mercy Internal Medicine Clinic Mason City, IA

Gout Treatment Guidelines

Anterior Ischemic Optic Neuropathy (AION)

A CRP B FBC C LFT D blood culture E uric acid

For the Patient: USMAVPEM

Cases I have Learned From. Jeffrey P. Callen, MD Professor of Medicine (Dermatology) University of Louisville

DISCUSSION BY: Dr M. R. Shakeebi, MD, Rheumatologist

1. To review the diagnosis of gout and its differential. 2. To understand the four stages of gout

AKI Case study -Vasculitis. Sarah Mackie Renal Practice Development Nurse King s College Hospital - London

NANOS Patient Brochure

Lab Values Explained. working at full strength. Other possible causes of an elevated BUN include dehydration and heart failure.

GIANT CELL ARTERITIS. Page 1 of 6 Reproduction of this material requires written permission of the Vasculitis Foundation. Copyright 2018.

Summary Article: Lupus (Systemic Lupus Erythematosus) from Harvard Medical School Health Topics A-Z

GOUT & PSEUDOGOUT OPSC 2018 HOWARD L. FEINBERG, D.O., F.A.C.O.I.., F.A.C.R.

An update on the management of gout

A Patient s Guide to Gout. Foot and Ankle Center of Massachusetts, P.C.

3/2/2014. Got Gout? Get a Plumber. Objectives. Disclosures

Secondary Gout Associated with Myeloproliferative Diseases* imt. Sinai Hospital

RENAL FAILURE IN CHILDREN Dr. Mai Mohamed Elhassan Assistant Professor Jazan University

RISK MANAGEMENT PLAN (RMP) PUBLIC SUMMARY ETORICOXIB ORION (ETORICOXIB) 30 MG, 60 MG, 90 MG & 120 MG FILM-COATED TABLET DATE: , VERSION 1.

The Joints are Painful & Swollen: Do I give Steroids? Dr Tom Kennedy

Chronic Kidney Disease. Dr Mohan B. Biyani A. Professor of Medicine University of Ottawa/Ottawa Hospital

Screening tests. When you need them and when you don t

Definition Chronic autoimmune disease The body s immune system starts attacking itself Can affect most organs and tissues in the body Brain, lungs, he

LUPUS CAN DO EVERYTHING, BUT NOT EVERYTHING IS LUPUS LUPUS 101 SLE SUBSETS AUTOIMMUNE DISEASE 11/4/2013 HOWARD HAUPTMAN, MD IDIOPATHIC DISCOID LUPUS

Difficult Diagnosis: Case History. 7 months prior, she happened to have undergone a C-spine MRI after a car accident

What a Rheumatologists needs to know about Nephrology. Dr Louise Moist University of Western Ontario

Arthritis & Rheumatology Clinics of Kansas PATIENT EDUCATION SYSTEMIC LUPUS ERYTHEMATOSUS

13. Behçet s - In Children

VASCULITIS. Case Presentation. Case Presentation

UNDERSTANDING SYSTEMIC LUPUS ERYTHEMATOSUS

Therapy for Gout: The Past

PAEDIATRIC VASCULITIS

Keeping track of your numbers

Myositis and Your Lungs

Atlas of the Vasculitic Syndromes

Corporate Medical Policy

Lecture 8 Gout Hinch. Pathogenesis of acute attacks

GPA & MPA GRANULOMATOSIS WITH POLYANGIITIS &MICROSCOPIC POLYANGIITIS. What you need to know about GPA & MPA

Gout Prevention Project. Simplifying Gout Prevention Management for GPs and Patients

Achieving Gout Goals in Your Practice An Interview with Paul P. Doghramji, MD, FAAFP

Vasculitis. Edward Dwyer, M.D. Division of Rheumatology. Vasculitis

New Drugs for the Primary Care Provider: What You Need to Know

9/25/2013 SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)

Scleritis LEN V KOH OD

Disclosures. Goals. Rheumatology Review for Primary Care. No commercial disclosures. We will be discussing non-fda approved uses for some medications.

Gout -revisited. Shrenik Shah

Lesinurad in Combination With a Xanthine Oxidase Inhibitor for Treatment of Hyperuricemia Associated With Gout

4/1/2011. New Developments in Gout. Conflict of Interest Declaration. Objectives

Learning about Lupus. Learning About Lupus. Lupus Society of Illinois

.,Dr Ali Alkazzaz Babylon collage of medicine 2016

Development of SLE among Possible SLE Patients Seen in Consultation: Long-Term Follow-Up. Disclosures. Background. Evidence-Based Medicine.

Transcription:

ACP Rheumatology Pearls Adam Q Carlson MD Assistant Professor UVA Rheumatology

Disclosures I have no personal or professional disclosures

Case #1 27 yo woman with a history of systemic lupus complicated by lupus nephritis contacts the clinic to let you know that she has unexpectedly become pregnant. Her lupus was diagnosed two years ago when she presented with rashes, arthritis, pericarditis, and renal insufficiency associated with proteinuria.

Case #1 Her serologies are notable for a high titer ANA, dsdna, SSA, and SSB. At diagnosis she has very low levels of C3 and C4. A kidney biopsy demonstrated Class III (proliferative) Lupus Nephritis At diagnosis she was started on high dose steroids, hydroxychloroquine, and mycophenolate. Her steroids had been tapered to a dose of 5 mg daily when she contacts the clinic.

Case #1: Question A Which of the following medications is NOT safe for use in lupus patients who are pregnant? 1. Prednisone 2. Mycophenolate 3. Azathioprine 4. Tacrolimus 5. Hydroxychloroquine

Case #1: Question A Which of the following medications is NOT safe for use in lupus patients who are pregnant? 1. Prednisone 2. Mycophenolate 3. Azathioprine 4. Tacrolimus 5. Hydroxychloroquine Hahn et al. Arth Care & Res. 2012 64 (6):797 808

Case #1 She stops Mycophenolate and starts Azathioprine in its place. She continues her hydroxychloroquine 2 months later she contacts you to let you know that she is short of breath and has new leg swelling. Labs done by her primary OB are notable for new renal insufficiency.

Case #1: Question B Which of the following is the best parameter to monitor for lupus nephritis activity in a patient with well established lupus and a history of nephritis 1. dsdna 2. C3 3. Creatinine 4. Urine Pr:Cr 5. ESR

Case #1: Question B Which of the following is the best parameter to monitor for lupus nephritis activity in a patient with well established lupus and a history of nephritis 1. dsdna 2. C3 3. Creatinine 4. Urine Pr:Cr 5. ESR Hahn et al. Arth Care & Res. 2012 64 (6):797 808

Case #1 She has 3 gm of proteinuria and her lupus parameters are all suggestive of active disease. She resumes a moderate dose of prednisone and tacrolimus is added to her regimen She develops refractory hypertension with worsening proteinuria. With concern for progressive renal disease her steroid dose is increased to 60 mg daily.

Case #1 Labs are notable worsening transaminases and falling platelets. She is diagnosed with HELLP and opts to terminate her pregnancy at 20 weeks She has rapid normalization of her blood pressure, proteinuria, cell counts, and transaminases within two weeks.

Case #2 71 yo female with acute onset of severe right sided occipital headache and right upper extremity pain associated with numbness, tingling, and pain following an iron infusion An ultrasound of the right upper extremity revealed a right brachial artery thrombus. During a CT scan of the head, she developed the sudden onset of severe right sided jaw pain and vision loss in the right eye.

Case #2 An urgent ophthalmology evaluation is notable for vitreous hemorrhage. ESR 80 She is started on prednisone 60 mg daily for possible GCA with dramatic improvement in her symptoms of claudication and headache. Her vision does not improve

Case #2 Question A You have 3 weeks after starting steroids to get a temporal artery biopsy 1. True 2. False

Case #2 Question A You have 3 weeks after starting steroids to get a temporal artery biopsy 1. True 2. False

Diagnostic yield of TA biopsy Ann Inter Med 1994;120:987-92

Case #2 A temporal artery biopsy was obtained that showed a 3.5 mm segment of vessel wall inflammation without classic findings of giant cells.

Case #2 A subsequent ophthalmologic evaluation raised concern for possible endophthalmitis for which she received intravitreal and systemic antibiotics. Vitreal cultures were collected but were not received in the microbiology lab She continued prednisone 60 mg daily

Case #2 Thrombectomy was performed in the right upper extremity. With broad spectrum antibiotics and antifungals along with prednisone, the patient reports gradual improvement in her symptoms. Her prednisone dose is reduced to 20 mg

Case #2 Once prednisone is tapered below 10 mg daily, she experiences return of right sided jaw pain and severe occipital headaches. Prednisone is restarted with improvement in her symptoms Ophthalmology re-evaluates patient and feels that that her vision loss was due to right optic nerve damage.

Case #3 Question B Other than the temporal arteries, what other branches of the external carotid are targets for potential biopsy 1. Lingual 2. Posterior Auricular 3. Occipital 4. Facial 5. Maxillary

Case #3 Question B Other than the temporal arteries, what other branches of the external carotid are targets for potential biopsy 1. Lingual 2. Posterior Auricular 3. Occipital 4. Facial 5. Maxillary NEJM 2002; 347: 261.

Netter, F. Atlas of Human Anatomy

Case #2 Question B If you receive a pathology report on a temporal artery biopsy that is negative or atypical for changes consistent with GCA, what it is next best step? 1. Ask Pathologist to take another look 2. Biopsy the other side 3. Biopsy another vessel 4. Perform a vascular ultrasound of other branches of the external carotid 5. Perform an MRA of the Great Vessels

Case #2 Question B If you receive a pathology report on a temporal artery biopsy that is negative or atypical for changes consistent with GCA, what it is next best step? 1. Ask Pathologist to take another look 2. Biopsy the other side 3. Biopsy another vessel 4. Perform a vascular ultrasound of other branches of the external carotid 5. Perform an MRA of the Great Vessels NEJM 2002; 347: 261.

Case #3 36 yo man with chronic tophaceous gout that began in his late teenage years. He has a heavy burden of tophi. His hyperuricemia is managed initially with Allopurinol and later transitioned to Febuxostat 80 mg. His current uric acid level is 8. His estimated GFR is 35 ml/min

Case #3: Question In a patient with Stage III CKD and tophaceous gout currently managed with febuxostat 80 mg daily but with a persistently elevated uric acid level of 8, what is the next most appropriate step: 1. Increase dose of Febuxostat 2. Add Probenecid 3. Add Pegloticase 4. Add Colchicine 5. Add Lensinurad

Case #3: Question In a patient with Stage III CKD and tophaceous gout currently managed with febuxostat (Uloric) 80 mg daily but with a persistently elevated uric acid level of 8, what is the next most appropriate step: 1. Increase dose of Febuxostat (Ulolric) 2. Add Probenecid 3. Add Pegloticase (Krystexxa) 4. Add Colchicine 5. Add Lensinurad (Zurampic)

CRYSTAL Trial Arthritis Rheumatol. 2017 Aug;69:1903-1913

Questions?